[Heart failure in patients over 80 years old]. 2019

Emmanuelle Berthelot, and Charlotte Nouhaud, and Carmelo Lafuente-Lafuente, and Patrick Assayag, and Luc Hittinger
AP-HP, hôpital Bicêtre, service de cardiologie, 94270 Le Kremlin-Bicêtre, France. Electronic address: emmanuelle.berthelot@aphp.fr.

Heart failure (HF) is a clinical syndrome that associates clinical signs in people over 80 years of age, an increase in natriuretic peptides and abnormal cardiac structures that result from cardiac aging in many cases. The most common symptoms are grouped according to the acronym "EPOF" (shortness of breath, weight gain, edema, fatigue). Over the age of 80, comorbidities must be taken into account. The incidence and prevalence of HF significantly increases with age and makes HF the most common reason for hospitalization for people over 80, and an important health expense. The management of HF, necessarily multidisciplinary with a geriatric evaluation, has improved over time due to effective targeted treatment, but mortality, hospitalization and readmission rates remain high. Therapeutic education and patient follow-up for treatment optimization are needed.

UI MeSH Term Description Entries
D010353 Patient Education as Topic The teaching or training of patients concerning their own health needs. Education of Patients,Education, Patient,Patient Education
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002317 Cardiovascular Agents Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. Cardioactive Agent,Cardioactive Drug,Cardiovascular Agent,Cardiovascular Drug,Cardioactive Agents,Cardioactive Drugs,Cardiovascular Drugs,Agent, Cardioactive,Agent, Cardiovascular,Drug, Cardioactive,Drug, Cardiovascular
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Emmanuelle Berthelot, and Charlotte Nouhaud, and Carmelo Lafuente-Lafuente, and Patrick Assayag, and Luc Hittinger
January 2017, Kardiologia polska,
Emmanuelle Berthelot, and Charlotte Nouhaud, and Carmelo Lafuente-Lafuente, and Patrick Assayag, and Luc Hittinger
April 2000, Intensive care medicine,
Emmanuelle Berthelot, and Charlotte Nouhaud, and Carmelo Lafuente-Lafuente, and Patrick Assayag, and Luc Hittinger
October 1969, Der Anaesthesist,
Emmanuelle Berthelot, and Charlotte Nouhaud, and Carmelo Lafuente-Lafuente, and Patrick Assayag, and Luc Hittinger
December 2003, Cochlear implants international,
Emmanuelle Berthelot, and Charlotte Nouhaud, and Carmelo Lafuente-Lafuente, and Patrick Assayag, and Luc Hittinger
December 1998, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
Emmanuelle Berthelot, and Charlotte Nouhaud, and Carmelo Lafuente-Lafuente, and Patrick Assayag, and Luc Hittinger
January 2004, Revista de neurologia,
Emmanuelle Berthelot, and Charlotte Nouhaud, and Carmelo Lafuente-Lafuente, and Patrick Assayag, and Luc Hittinger
October 2011, Digestive diseases and sciences,
Emmanuelle Berthelot, and Charlotte Nouhaud, and Carmelo Lafuente-Lafuente, and Patrick Assayag, and Luc Hittinger
January 2012, Hepato-gastroenterology,
Emmanuelle Berthelot, and Charlotte Nouhaud, and Carmelo Lafuente-Lafuente, and Patrick Assayag, and Luc Hittinger
September 1981, Schweizerische medizinische Wochenschrift,
Emmanuelle Berthelot, and Charlotte Nouhaud, and Carmelo Lafuente-Lafuente, and Patrick Assayag, and Luc Hittinger
April 1973, La Nouvelle presse medicale,
Copied contents to your clipboard!